• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于运动的评估和干预措施用于结缔组织疾病相关肺动脉高压。

Exercise-based evaluations and interventions for pulmonary hypertension with connective tissue disorders.

机构信息

a Department of Physiotherapy , School of Allied Health Sciences, Manipal Academy of Higher Education , Manipal , Karnataka , India.

b Department of Cardiology/Medicine, Austin Health, Faculty of Medicine, Dentistry & Health Sciences , University of Melbourne , Melbourne , Australia.

出版信息

Expert Rev Respir Med. 2018 Jul;12(7):615-622. doi: 10.1080/17476348.2018.1481393. Epub 2018 Jun 1.

DOI:10.1080/17476348.2018.1481393
PMID:29798690
Abstract

Exercise intolerance is a common and often significant limitation in pulmonary arterial hypertension (PAH). This intolerance greatly affects the quality of life and function of the individual with PAH, irrespective of its etiology. In PAH associated with connective tissue disorders (PAH-CTD), exercise intolerance is further amplified by the presence of coexisting musculoskeletal manifestations of CTD. The evaluation of exercise capacity and prescription for exercise training therefore becomes a challenge to the clinician. Areas covered: This review highlights factors contributing to exercise intolerance in PAH-CTD, evaluation methods of exercise capacity and an overview on exercise training and a roadmap for future research. Expert commentary: Exercise intolerance is a complex interplay of cardiovascular, pulmonary, and musculoskeletal systems. Data from cardiopulmonary exercise tests have shown predictive abilities for both diagnosis and prognosis. In its absence, the 6-min walk test can be used to provide similar information thereby making the role of exercise testing an invaluable evaluation method in PAH-CTD. Exercise training data in PAH-CTD are still sparse, though, data from PAH studies suggest potential benefit. However, more research is required in this area of testing and training for greater understanding on exercise hemodynamic, phenotypes, and training benefits.

摘要

运动不耐受是肺动脉高压(PAH)的常见且常较为严重的限制因素。无论其病因如何,这种不耐受都会极大地影响 PAH 患者的生活质量和功能。在与结缔组织疾病相关的 PAH(PAH-CTD)中,CTD 共存的肌肉骨骼表现进一步放大了运动不耐受。因此,评估运动能力和制定运动训练处方对临床医生来说是一个挑战。涵盖领域:本文综述了导致 PAH-CTD 运动不耐受的因素,运动能力评估方法以及运动训练概述和未来研究的路线图。专家评论:运动不耐受是心血管、肺部和肌肉骨骼系统复杂相互作用的结果。心肺运动试验的数据显示出对诊断和预后的预测能力。在缺乏心肺运动试验的情况下,6 分钟步行试验可提供类似信息,从而使运动试验成为 PAH-CTD 中一种非常有价值的评估方法。然而,该领域的测试和训练仍缺乏 PAH-CTD 的相关数据,尽管 PAH 研究的数据表明可能存在获益。但是,需要在这一测试和训练领域开展更多的研究,以更好地了解运动血流动力学、表型和训练获益。

相似文献

1
Exercise-based evaluations and interventions for pulmonary hypertension with connective tissue disorders.基于运动的评估和干预措施用于结缔组织疾病相关肺动脉高压。
Expert Rev Respir Med. 2018 Jul;12(7):615-622. doi: 10.1080/17476348.2018.1481393. Epub 2018 Jun 1.
2
Pulmonary arterial hypertension complicating connective tissue diseases.结缔组织病合并肺动脉高压。
Semin Respir Crit Care Med. 2009 Aug;30(4):429-39. doi: 10.1055/s-0029-1233312. Epub 2009 Jul 24.
3
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.现代治疗时代的结缔组织病相关肺动脉高压
Am J Respir Crit Care Med. 2009 Jan 15;179(2):151-7. doi: 10.1164/rccm.200806-953OC. Epub 2008 Oct 17.
4
Pulmonary arterial hypertension in connective tissue diseases.结缔组织病相关性肺动脉高压。
Cardiol Rev. 2010 Mar-Apr;18(2):85-8. doi: 10.1097/CRD.0b013e3181cbcde7.
5
[Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].[儿童结缔组织病继发肺动脉高压的临床分析]
Zhonghua Er Ke Za Zhi. 2008 Nov;46(11):822-6.
6
[Pulmonary arterial hypertension associated with connective tissue diseases].[与结缔组织病相关的肺动脉高压]
Presse Med. 2014 Sep;43(9):957-69. doi: 10.1016/j.lpm.2014.07.009. Epub 2014 Aug 14.
7
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.波生坦治疗与结缔组织病相关的肺动脉高压:关键临床试验及其开放标签扩展研究的亚组分析
Ann Rheum Dis. 2006 Oct;65(10):1336-40. doi: 10.1136/ard.2005.048967. Epub 2006 Jun 22.
8
Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.特发性与结缔组织病相关肺动脉高压的治疗反应比较。
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1111-7. doi: 10.1164/rccm.201507-1456OC.
9
[Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].[心肺运动试验在比较三种肺动脉高压患者心肺功能中的价值]
Zhonghua Yi Xue Za Zhi. 2015 Nov 24;95(44):3598-601.
10
Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.美国结缔组织疾病相关性肺动脉高压患者的真实世界治疗模式:一项回顾性基于索赔的分析。
Adv Ther. 2023 Nov;40(11):5037-5054. doi: 10.1007/s12325-023-02658-z. Epub 2023 Sep 20.

引用本文的文献

1
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients?如何评估系统性硬化症患者的肺循环和右心腔?
Diagnostics (Basel). 2025 Apr 17;15(8):1029. doi: 10.3390/diagnostics15081029.